Pitney Bowes (PBI) Financials

Pitney Bowes logo
$15.39 -0.20 (-1.30%)
Closing price 03:59 PM Eastern
Extended Trading
$15.36 -0.03 (-0.17%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Pitney Bowes

Annual Income Statements for Pitney Bowes

This table shows Pitney Bowes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
408 93 244 2,668 194 -180 -1.35 37 -386 -204 145
Consolidated Net Income / (Loss)
426 112 244 242 194 -180 -1.35 37 -386 -204 145
Net Income / (Loss) Continuing Operations
421 95 180 2,608 40 -190 3.51 146 -61 103 145
Total Pre-Tax Income
611 202 194 2,614 27 -183 -7.42 189 -44 -52 193
Total Operating Income
604 -35 312 2,729 162 -78 89 240 55 58 294
Total Gross Profit
2,019 1,421 1,456 3,847 1,283 1,149 1,122 1,153 1,114 1,143 1,085
Total Revenue
3,578 2,656 2,784 5,637 3,205 3,554 3,674 2,483 2,079 2,027 1,893
Operating Revenue
3,578 2,656 2,784 5,637 3,205 3,554 3,674 2,483 2,079 2,027 1,893
Total Cost of Revenue
1,559 1,235 1,328 1,790 1,923 2,405 2,552 1,330 965 883 807
Operating Cost of Revenue
1,559 1,235 1,328 1,790 1,923 2,405 2,552 1,330 965 883 807
Total Operating Expenses
1,416 1,456 1,144 1,118 1,121 1,227 1,033 913 1,059 1,086 791
Selling, General & Admin Expense
1,280 1,140 1,029 1,003 1,004 963 924 786 782 718 622
Research & Development Expense
110 107 61 59 51 38 47 35 29 32 15
Other Operating Expenses / (Income)
- - 5.41 22 -4.23 -1.71 1.01 92 75 170 69
Impairment Charge
0.00 148 - 0.00 0.00 198 0.00 0.00 124 0.00 0.00
Restructuring Charge
26 60 45 26 70 21 19 17 52 77 59
Other Special Charges / (Income)
- - 3.86 7.96 - 8.15 42 -17 -3.06 89 27
Total Other Income / (Expense), net
7.26 237 -118 -115 -135 -106 -97 -52 -99 -110 -101
Interest Expense
88 89 118 115 111 106 97 52 99 110 101
Income Tax Expense
190 107 14 6.42 -13 7.12 -11 43 17 -155 48
Net Income / (Loss) Discontinued Operations
5.27 17 63 60 154 10 -4.86 -109 -324 -306 0.00
Basic Earnings per Share
$2.04 $0.49 $1.31 $1.29 $1.10 ($1.05) ($0.01) $0.21 ($2.20) ($1.13) $0.84
Weighted Average Basic Shares Outstanding
199.84M 187.95M 186.33M 188.24M 171.15M 173.27M 174.86M 174.18M 176.53M 182.79M 149.94M
Diluted Earnings per Share
$2.03 $0.49 $1.30 $1.28 $1.10 ($1.05) ($0.01) $0.21 ($2.20) ($1.12) $0.84
Weighted Average Diluted Shares Outstanding
199.84M 187.95M 186.33M 188.24M 171.15M 173.27M 174.86M 174.18M 176.53M 182.79M 149.94M
Weighted Average Basic & Diluted Shares Outstanding
199.84M 187.95M 186.33M 188.24M 171.15M 173.27M 174.86M 174.18M 176.53M 182.79M 149.94M
Cash Dividends to Common per Share
$0.75 $0.75 $0.75 $0.75 $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 $0.30

Quarterly Income Statements for Pitney Bowes

This table shows Pitney Bowes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-2.89 -25 -138 -37 35 30 52 27 58 50 53
Consolidated Net Income / (Loss)
-2.89 -25 -138 -37 35 30 52 27 58 50 53
Net Income / (Loss) Continuing Operations
32 -10 123 7.67 35 30 52 27 58 50 53
Total Pre-Tax Income
48 -7.85 -44 21 47 39 68 38 80 65 70
Total Operating Income
75 20 -16 7.71 89 64 109 65 119 94 108
Total Gross Profit
294 250 261 298 287 263 259 324 273 255 259
Total Revenue
521 490 499 -97 493 462 460 478 477 451 456
Operating Revenue
521 490 499 -97 493 462 460 478 477 451 456
Total Cost of Revenue
227 239 238 -395 207 199 201 153 205 197 197
Operating Cost of Revenue
227 239 238 -395 207 199 201 153 205 197 197
Total Operating Expenses
219 230 278 290 198 199 150 260 153 161 151
Selling, General & Admin Expense
187 193 190 92 166 171 144 141 133 129 139
Research & Development Expense
7.63 7.26 7.58 5.79 4.76 3.60 3.41 3.51 3.79 3.38 3.38
Other Operating Expenses / (Income)
21 -0.38 -0.96 144 1.85 18 1.65 64 11 25 10
Restructuring Charge
3.77 30 31 10 1.40 14 1.84 42 5.11 3.34 1.53
Other Special Charges / (Income)
0.00 0.00 50 38 24 -6.58 -0.98 10 0.00 0.48 -3.16
Total Other Income / (Expense), net
-27 -28 -28 13 -42 -25 -41 -26 -39 -29 -38
Interest Expense
27 28 28 -13 42 25 41 26 39 29 38
Income Tax Expense
16 2.27 -166 13 11 9.30 16 11 22 16 17
Basic Earnings per Share
($0.02) ($0.14) ($0.77) ($0.20) $0.19 $0.17 $0.31 $0.17 $0.40 $0.37 $0.39
Weighted Average Basic Shares Outstanding
178.88M 179.51M 181.70M 182.79M 181.25M 172.12M 160.92M 149.94M 135.44M 137.09M 135.55M
Diluted Earnings per Share
($0.02) ($0.14) ($0.75) ($0.21) $0.19 $0.17 $0.30 $0.18 $0.39 $0.36 $0.37
Weighted Average Diluted Shares Outstanding
178.88M 179.51M 181.70M 182.79M 181.25M 172.12M 160.92M 149.94M 135.44M 137.09M 135.55M
Weighted Average Basic & Diluted Shares Outstanding
178.88M 179.51M 181.70M 182.79M 181.25M 172.12M 160.92M 149.94M 135.44M 137.09M 135.55M

Annual Cash Flow Statements for Pitney Bowes

This table details how cash moves in and out of Pitney Bowes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-403 124 201 -114 57 -2.99 -189 -63 -68 -130 -185
Net Cash From Operating Activities
523 496 454 345 268 302 302 175 80 229 383
Net Cash From Continuing Operating Activities
523 403 401 353 259 340 302 341 235 276 383
Net Income / (Loss) Continuing Operations
426 95 180 182 40 -190 3.51 146 -61 103 145
Consolidated Net Income / (Loss)
426 112 244 242 194 -180 -1.35 37 -386 -204 145
Net Income / (Loss) Discontinued Operations
- 17 63 60 154 10 -4.86 -109 -324 -306 0.00
Depreciation Expense
173 174 127 148 159 161 163 111 113 114 112
Amortization Expense
- - - 6.77 10 11 7.16 8.67 11 13 7.23
Non-Cash Adjustments To Reconcile Net Income
-82 182 69 113 146 294 65 1.36 182 216 98
Changes in Operating Assets and Liabilities, net
5.11 -48 25 -97 -96 65 63 74 -9.07 -170 21
Net Cash From Discontinued Operating Activities
- 93 53 -7.92 9.27 -38 - -166 -155 -47 0.00
Net Cash From Investing Activities
-303 -116 -621 286 458 -76 -155 -24 -124 -49 -125
Net Cash From Continuing Investing Activities
-303 -114 -616 -48 -213 -73 -153 18 -99 -42 -125
Purchase of Property, Plant & Equipment
-167 -159 -118 -138 -137 -105 -184 -83 -78 -72 -66
Acquisitions
-394 -38 -483 -10 -22 -6.61 -15 -5.14 0.00 0.00 -2.20
Purchase of Investments
-274 -213 -133 -84 -153 -601 -81 -90 -48 -40 -96
Sale and/or Maturity of Investments
207 287 114 176 109 635 99 79 25 77 28
Other Investing Activities, net
-17 -9.09 5.20 8.17 -8.91 4.64 0.00 4.26 1.61 -6.27 11
Net Cash From Discontinued Investing Activities
- -1.60 -5.63 335 670 -2.50 -1.77 -42 -25 -7.39 0.00
Net Cash From Financing Activities
-579 -230 368 -745 -670 -235 -330 -198 -30 -305 -445
Net Cash From Continuing Financing Activities
-579 -230 368 -745 -670 -235 -330 -188 -22 -299 -445
Repayment of Debt
-519 -468 -965 -626 -936 -1,144 -1,506 -136 -340 -252 -946
Repurchase of Common Equity
-132 -497 0.00 0.00 -105 0.00 0.00 -13 0.00 0.00 -378
Payment of Dividends
-168 -159 -139 -140 -35 -34 -35 -35 -35 -36 -51
Issuance of Debt
241 895 1,472 0.00 390 917 1,196 0.00 267 0.00 1,005
Other Financing Activities, net
- - - 21 16 26 15 -3.99 86 -10 -75
Net Cash From Discontinued Financing Activities
- - - - - - - -9.62 -8.00 -6.86 0.00
Effect of Exchange Rate Changes
-44 -27 - - 2.05 6.10 -4.86 -16 5.73 -4.99 2.36

Quarterly Cash Flow Statements for Pitney Bowes

This table details how cash moves in and out of Pitney Bowes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-85 74 -28 -92 -146 -39 36 -36 18 -36 1.68
Net Cash From Operating Activities
-13 93 14 134 -17 111 67 222 44 153 151
Net Cash From Continuing Operating Activities
-1.02 93 64 132 -17 111 67 222 44 153 151
Net Income / (Loss) Continuing Operations
32 -25 172 -42 35 30 52 27 58 50 53
Consolidated Net Income / (Loss)
-2.89 -25 -138 -37 35 30 52 27 58 50 53
Depreciation Expense
29 41 4.28 29 28 29 27 27 26 24 23
Amortization Expense
3.07 3.10 3.30 3.45 2.15 1.45 1.72 1.91 1.96 2.02 1.63
Non-Cash Adjustments To Reconcile Net Income
-4.56 35 92 90 29 32 4.44 33 -1.37 39 -7.06
Changes in Operating Assets and Liabilities, net
-60 39 -207 52 -112 19 -19 132 -40 38 81
Net Cash From Investing Activities
-12 -16 -39 17 -46 -29 -36 -15 -9.29 -17 -1.92
Net Cash From Continuing Investing Activities
-6.20 -16 -27 14 -46 -29 -36 -15 -9.29 -17 -1.92
Purchase of Property, Plant & Equipment
-14 -21 -9.13 -22 -17 -13 -16 -20 -16 -18 -11
Purchase of Investments
-16 -7.49 -3.68 -12 -41 -28 -28 0.80 -0.97 -2.71 4.89
Sale and/or Maturity of Investments
24 13 12 28 13 5.19 5.31 4.50 7.30 3.76 3.90
Net Cash From Financing Activities
-58 -2.37 -7.21 -237 -85 -123 6.11 -243 -16 -171 -148
Net Cash From Continuing Financing Activities
-56 -2.37 -0.36 -237 -85 -123 6.11 -243 -16 -171 -148
Repayment of Debt
-18 -22 -7.27 -203 -807 -19 -12 -108 -6.87 -362 -227
Repurchase of Common Equity
0.00 - - - -15 -75 -162 -127 -136 -53 -17
Payment of Dividends
-8.83 -8.95 -9.06 -9.11 -11 -13 -13 -14 -13 -14 -14
Issuance of Debt
0.00 - - - 775 - 230 - 148 249 80
Other Financing Activities, net
-29 29 16 -26 -27 -16 -37 5.44 -8.33 8.58 31
Effect of Exchange Rate Changes
-2.15 -0.55 3.88 -6.15 1.34 1.99 -0.71 -0.27 -0.46 -0.44 0.05

Annual Balance Sheets for Pitney Bowes

This table presents Pitney Bowes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
6,123 5,837 6,687 5,938 5,467 5,224 4,959 4,741 4,272 3,398 3,169
Total Current Assets
2,325 2,325 2,830 2,698 2,236 2,113 1,892 1,798 2,058 1,318 1,100
Cash & Equivalents
640 765 1,009 867 924 921 732 670 600 470 285
Short-Term Investments
127 38 49 59 116 19 14 11 22 16 12
Note & Lease Receivable
918 894 828 653 630 568 561 565 564 536 496
Accounts Receivable
477 456 427 372 373 389 335 344 200 160 168
Inventories, net
89 93 41 62 68 71 79 84 63 60 66
Prepaid Expenses
67 69 83 75 102 120 157 116 76 66 69
Current Deferred & Refundable Income Taxes
6.58 11 58 5.95 5.57 23 14 8.79 0.56 10 3.14
Plant, Property, & Equipment, net
330 315 374 399 376 391 464 448 24 243 210
Total Noncurrent Assets
3,468 3,197 3,484 2,842 2,855 2,721 2,603 2,495 2,191 1,836 1,858
Noncurrent Note & Lease Receivables
761 673 652 636 625 605 587 627 653 610 605
Goodwill
1,746 1,571 1,775 1,332 1,324 1,152 1,135 1,067 734 721 747
Intangible Assets
187 165 272 213 191 160 132 78 20 16 15
Noncurrent Deferred & Refundable Income Taxes
70 75 60 65 72 71 68 47 61 100 95
Other Noncurrent Operating Assets
703 713 725 596 642 732 680 677 722 389 397
Total Liabilities & Shareholders' Equity
6,123 5,837 6,687 5,938 5,467 5,224 4,959 4,741 4,272 3,398 3,169
Total Liabilities
5,648 5,941 6,499 5,837 5,181 5,154 4,846 4,681 4,641 3,976 3,971
Total Current Liabilities
2,279 2,328 2,069 1,890 1,570 1,870 1,728 1,728 1,898 1,673 1,548
Short-Term Debt
461 614 271 200 20 216 25 33 59 53 17
Accounts Payable
1,448 1,379 1,459 1,348 794 881 923 907 829 874 845
Customer Deposits
- - - - 591 617 632 628 640 646 583
Current Deferred Revenue
353 300 258 117 102 115 99 105 76 70 69
Current Deferred & Payable Income Tax Liabilities
17 34 8.82 15 17 2.88 9.02 2.10 6.52 2.95 5.21
Other Current Liabilities
- - - 35 36 39 40 53 30 27 28
Total Noncurrent Liabilities
3,369 3,613 4,430 3,947 3,611 3,283 3,118 2,953 2,742 2,303 2,423
Long-Term Debt
2,490 2,750 3,559 3,066 2,720 2,348 2,299 2,173 2,087 1,866 1,976
Noncurrent Deferred & Payable Income Tax Liabilities
274 266 351 293 313 318 318 287 231 63 73
Other Noncurrent Operating Liabilities
605 597 519 588 578 617 501 493 425 374 375
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
179 -104 189 102 286 71 113 61 -369 -578 -802
Total Preferred & Common Equity
179 -104 189 102 286 71 113 61 -369 -578 -802
Total Common Equity
179 -104 189 102 286 71 113 61 -369 -578 -802
Common Stock
485 471 462 445 422 392 326 323 270 270 270
Retained Earnings
5,156 5,108 5,230 5,280 5,439 5,205 5,169 5,126 3,078 2,672 2,656
Treasury Stock
-4,573 -4,743 -4,711 -4,674 -4,735 -4,688 -4,602 -4,553 -2,866 -2,681 -2,939
Accumulated Other Comprehensive Income / (Loss)
-889 -940 -792 -949 -840 -839 -780 -836 -851 -839 -789

Quarterly Balance Sheets for Pitney Bowes

This table presents Pitney Bowes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
4,423 4,423 4,103 4,078 3,648 3,270 3,239 3,255 3,147 3,020 2,992
Total Current Assets
1,615 1,618 1,582 1,606 1,486 1,185 1,126 1,150 1,129 1,040 1,045
Cash & Equivalents
542 558 516 590 562 324 285 321 303 267 269
Short-Term Investments
19 22 22 22 14 16 16 15 11 12 13
Note & Lease Receivable
560 550 547 542 531 526 507 498 482 469 462
Accounts Receivable
273 289 307 266 189 160 155 162 159 148 162
Inventories, net
93 84 79 77 72 65 79 76 63 63 63
Prepaid Expenses
117 109 110 101 100 92 83 74 110 79 74
Current Deferred & Refundable Income Taxes
11 6.39 0.99 7.85 20 0.98 1.30 4.31 2.68 2.42 2.42
Plant, Property, & Equipment, net
428 416 393 22 24 229 216 207 204 198 194
Total Noncurrent Assets
2,381 2,389 2,128 2,450 2,138 1,856 1,897 1,899 1,814 1,782 1,754
Noncurrent Note & Lease Receivables
640 641 638 626 622 624 639 624 571 551 533
Goodwill
952 945 729 728 737 730 749 747 743 740 739
Intangible Assets
70 66 58 54 17 18 17 16 14 13 12
Noncurrent Deferred & Refundable Income Taxes
45 55 59 58 91 101 104 102 93 90 98
Other Noncurrent Operating Assets
674 681 643 985 670 383 389 410 394 388 371
Total Liabilities & Shareholders' Equity
4,423 4,423 4,103 4,078 3,648 3,270 3,239 3,255 3,147 3,020 2,992
Total Liabilities
4,499 4,548 4,495 4,506 4,167 3,806 3,776 3,917 4,041 3,883 3,829
Total Current Liabilities
1,857 1,641 1,625 1,678 1,685 1,489 1,489 1,422 1,818 1,418 1,497
Short-Term Debt
265 57 58 57 56 14 15 16 364 23 25
Accounts Payable
812 794 784 843 853 744 743 699 767 743 796
Customer Deposits
639 643 600 629 671 625 609 602 574 547 577
Current Deferred Revenue
83 88 89 86 74 75 76 73 73 72 67
Current Deferred & Payable Income Tax Liabilities
2.93 1.82 34 1.56 1.47 3.53 19 4.91 11 3.12 2.80
Other Current Liabilities
54 58 60 61 29 27 27 27 29 30 30
Total Noncurrent Liabilities
2,642 2,907 2,870 2,828 2,482 2,317 2,287 2,495 2,222 2,465 2,332
Long-Term Debt
1,885 2,102 2,076 2,065 2,052 1,899 1,882 2,088 1,774 2,011 1,863
Noncurrent Deferred & Payable Income Tax Liabilities
262 260 219 208 69 65 54 71 82 98 112
Other Noncurrent Operating Liabilities
496 546 575 555 360 353 352 336 366 357 357
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-75 -125 -392 -428 -519 -536 -537 -662 -894 -863 -837
Total Preferred & Common Equity
-75 -125 -392 -428 -519 -536 -537 -662 -894 -863 -837
Total Common Equity
-75 -125 -392 -428 -519 -536 -537 -662 -894 -863 -837
Common Stock
323 323 270 270 270 270 270 270 270 270 270
Retained Earnings
4,909 4,872 3,027 2,949 2,748 2,652 2,670 2,657 2,689 2,699 2,740
Treasury Stock
-4,499 -4,483 -2,826 -2,782 -2,717 -2,646 -2,713 -2,824 -3,061 -3,042 -3,057
Accumulated Other Comprehensive Income / (Loss)
-808 -838 -864 -866 -821 -812 -764 -765 -792 -790 -790

Annual Metrics And Ratios for Pitney Bowes

This table displays calculated financial ratios and metrics derived from Pitney Bowes' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-6.37% -25.78% 4.83% 102.49% -43.15% 10.89% 3.36% -32.41% -16.27% -2.52% -6.61%
EBITDA Growth
21.04% -46.68% -5.67% 557.88% -89.35% -69.45% 176.41% 38.84% -60.37% -2.88% 122.94%
EBIT Growth
33.77% -58.37% 7.20% 775.69% -94.96% -156.39% 215.27% 168.74% -91.95% -41.77% 408.91%
NOPAT Growth
-0.77% -103.93% 1,870.82% 839.81% -91.13% -122.50% 215.27% 196.49% -92.70% -41.77% 446.41%
Net Income Growth
21.07% -73.76% 117.73% -0.71% -19.64% -192.82% 99.25% 2,834.27% -1,143.93% 47.20% 171.07%
EPS Growth
23.78% -75.86% 165.31% -1.54% -14.06% -195.45% 99.05% 2,200.00% -1,147.62% 49.09% 175.00%
Operating Cash Flow Growth
-20.55% -5.14% -8.46% -24.11% -22.27% 12.73% -0.15% -41.95% -54.24% 186.14% 67.24%
Free Cash Flow Firm Growth
-71.89% -19.48% -73.24% 6,840.16% -91.90% -17.09% -70.46% 329.26% 147.32% -95.46% 180.17%
Invested Capital Growth
7.61% -7.52% 9.79% -25.42% -1.73% -14.33% -0.30% -6.20% -44.48% -2.81% 4.49%
Revenue Q/Q Growth
-1.30% -23.17% -12.09% 97.87% -49.27% 5.15% 60.22% -31.28% -31.22% -38.13% -1.99%
EBITDA Q/Q Growth
15.62% -32.30% -59.94% 6,368.14% -91.33% -47.91% 121.71% 25.75% 30.96% 325.26% 45.67%
EBIT Q/Q Growth
22.15% -41.91% -66.51% 1,860.01% -95.94% -983.81% 106.55% 114.83% 180.42% 104.78% 82.03%
NOPAT Q/Q Growth
5.31% -104.89% -36.34% 1,804.77% -92.96% -983.81% 101.97% 73.59% 180.42% 104.78% 92.50%
Net Income Q/Q Growth
5.90% -60.95% 163.81% -8.40% 186.26% -651.03% -107.75% 15.76% -148.00% 47.80% 80.90%
EPS Q/Q Growth
6.84% -64.23% 170.83% -8.57% 205.56% -517.65% -110.00% 16.67% -150.00% 48.86% 86.67%
Operating Cash Flow Q/Q Growth
-14.58% 6.02% -14.36% -9.81% -0.18% 9.11% -7.79% 85.09% -47.60% 21.85% 29.46%
Free Cash Flow Firm Q/Q Growth
-52.58% -22.66% -92.90% 1,176.48% -93.26% 24.89% 102.28% 94.23% 447.08% -88.10% 709.66%
Invested Capital Q/Q Growth
-0.82% -11.49% 6.20% -25.41% -2.62% -8.60% 2.75% -1.06% -39.47% -15.69% -19.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
56.44% 53.51% 52.30% 68.24% 40.02% 32.34% 30.54% 46.45% 52.62% 55.56% 57.35%
EBITDA Margin
24.36% 17.50% 15.75% 51.17% 9.59% 2.64% 7.06% 14.51% 6.87% 6.84% 21.81%
Operating Margin
16.87% -1.31% 11.20% 48.42% 5.05% -2.18% 2.44% 9.68% 0.93% 0.56% 15.53%
EBIT Margin
19.52% 10.95% 11.20% 48.42% 4.29% -2.18% 2.44% 9.68% 0.93% 0.56% 15.53%
Profit (Net Income) Margin
11.91% 4.21% 8.75% 4.29% 6.06% -5.08% -0.04% 1.49% -18.55% -10.05% 7.65%
Tax Burden Percent
69.79% 55.43% 125.73% 9.25% 726.92% 98.37% 18.22% 19.58% 878.02% 389.09% 75.16%
Interest Burden Percent
87.46% 69.40% 62.15% 95.77% 19.42% 236.25% -8.29% 78.46% -226.85% -464.18% 65.49%
Effective Tax Rate
31.07% 53.01% 7.05% 0.25% -49.11% 0.00% 0.00% 22.77% 0.00% 0.00% 24.84%
Return on Invested Capital (ROIC)
16.23% -0.64% 11.24% 115.57% 12.10% -2.96% 3.70% 11.34% 1.10% 0.91% 25.27%
ROIC Less NNEP Spread (ROIC-NNEP)
16.71% 4.76% 9.41% 3.35% 9.48% -10.56% -0.30% 1.75% -27.70% -14.86% 20.40%
Return on Net Nonoperating Assets (RNNOA)
84.24% 60.87% 562.44% 50.96% 88.08% -98.17% -5.18% 31.29% 249.37% 42.09% -46.23%
Return on Equity (ROE)
100.46% 60.23% 573.68% 166.53% 100.18% -101.13% -1.47% 42.64% 250.47% 43.00% -20.96%
Cash Return on Invested Capital (CROIC)
8.89% 7.18% 1.90% 144.70% 13.85% 12.47% 4.00% 17.74% 58.30% 3.76% 20.88%
Operating Return on Assets (OROA)
11.07% 4.86% 4.98% 43.23% 2.41% -1.45% 1.76% 4.96% 0.43% 0.29% 8.95%
Return on Assets (ROA)
6.75% 1.87% 3.89% 3.83% 3.41% -3.37% -0.03% 0.76% -8.56% -5.31% 4.41%
Return on Common Equity (ROCE)
30.30% 12.17% 573.66% 166.53% 100.18% -101.13% -1.47% 42.64% 250.47% 43.00% -20.96%
Return on Equity Simple (ROE_SIMPLE)
238.54% -107.90% 129.15% 237.44% 67.92% -255.41% -1.20% 60.90% 104.63% 35.20% 0.00%
Net Operating Profit after Tax (NOPAT)
416 -16 290 2,723 241 -54 63 186 14 7.89 221
NOPAT Margin
11.63% -0.62% 10.41% 48.30% 7.53% -1.53% 1.70% 7.48% 0.65% 0.39% 11.67%
Net Nonoperating Expense Percent (NNEP)
-0.48% -5.40% 1.82% 112.23% 2.62% 7.60% 4.00% 9.59% 28.79% 15.77% 4.87%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 8.20% 0.76% 0.59% 18.56%
Cost of Revenue to Revenue
43.56% 46.49% 47.70% 31.76% 59.98% 67.66% 69.46% 53.55% 47.38% 44.44% 42.65%
SG&A Expenses to Revenue
35.77% 42.93% 36.98% 17.79% 31.32% 27.10% 25.16% 31.64% 37.60% 35.42% 32.84%
R&D to Revenue
3.08% 4.04% 2.19% 1.04% 1.60% 1.08% 1.27% 1.43% 1.42% 1.58% 0.81%
Operating Expenses to Revenue
39.57% 54.82% 41.11% 19.83% 34.96% 34.52% 28.11% 36.76% 51.69% 55.00% 41.81%
Earnings before Interest and Taxes (EBIT)
698 291 312 2,729 138 -78 89 240 19 11 294
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
872 465 438 2,885 307 94 259 360 143 139 413
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
14.68 0.00 7.92 8.47 1.95 12.88 9.06 9.90 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.73 0.72 0.54 0.15 0.17 0.26 0.28 0.24 0.36 0.65 0.90
Price to Earnings (P/E)
6.43 20.49 6.14 0.32 2.87 0.00 0.00 16.26 0.00 0.00 11.75
Dividend Yield
5.63% 7.33% 9.37% 16.32% 6.12% 3.81% 3.45% 5.79% 4.74% 2.78% 3.31%
Earnings Yield
15.55% 4.88% 16.30% 309.32% 34.80% 0.00% 0.00% 6.15% 0.00% 0.00% 8.51%
Enterprise Value to Invested Capital (EV/IC)
1.92 1.82 1.58 1.59 1.14 1.50 1.54 1.34 2.58 3.21 3.80
Enterprise Value to Revenue (EV/Rev)
1.43 1.68 1.53 0.57 0.70 0.71 0.71 0.86 1.09 1.35 1.79
Enterprise Value to EBITDA (EV/EBITDA)
5.85 9.60 9.73 1.11 7.35 26.99 10.01 5.90 15.88 19.77 8.23
Enterprise Value to EBIT (EV/EBIT)
7.31 15.35 13.69 1.17 16.40 0.00 29.03 8.84 117.13 243.21 11.55
Enterprise Value to NOPAT (EV/NOPAT)
12.27 0.00 14.73 1.18 9.35 0.00 41.48 11.44 167.33 347.45 15.37
Enterprise Value to Operating Cash Flow (EV/OCF)
9.76 9.00 9.39 9.29 8.43 8.39 8.62 12.14 28.32 11.96 8.86
Enterprise Value to Free Cash Flow (EV/FCFF)
22.38 24.32 86.87 0.94 8.17 11.06 38.39 7.31 3.16 84.06 18.61
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
6.21 -32.46 20.31 32.07 9.58 36.31 20.63 36.36 -5.82 -3.32 -2.48
Long-Term Debt to Equity
5.24 -26.53 18.88 30.11 9.51 33.25 20.41 35.82 -5.66 -3.23 -2.46
Financial Leverage
5.04 12.77 59.74 15.22 9.29 9.30 17.47 17.90 -9.00 -2.83 -2.27
Leverage Ratio
14.87 32.20 147.52 43.48 29.40 29.97 55.57 55.98 -29.27 -8.10 -4.76
Compound Leverage Factor
13.01 22.35 91.68 41.64 5.71 70.81 -4.61 43.92 66.40 37.59 -3.11
Debt to Total Capital
86.13% 103.18% 95.31% 96.98% 90.54% 97.32% 95.38% 97.32% 120.74% 143.13% 167.39%
Short-Term Debt to Total Capital
13.46% 18.84% 6.74% 5.93% 0.66% 8.20% 1.02% 1.45% 3.32% 3.97% 1.44%
Long-Term Debt to Total Capital
72.67% 84.34% 88.56% 91.05% 89.88% 89.12% 94.36% 95.88% 117.42% 139.16% 165.95%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
8.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
5.22% -3.18% 4.69% 3.02% 9.46% 2.68% 4.62% 2.68% -20.74% -43.13% -67.39%
Debt to EBITDA
3.38 7.24 8.74 1.13 8.92 27.32 8.96 6.12 15.03 13.84 4.83
Net Debt to EBITDA
2.50 5.51 6.32 0.81 5.53 17.30 6.08 4.23 10.67 10.34 4.11
Long-Term Debt to EBITDA
2.86 5.92 8.12 1.06 8.85 25.01 8.86 6.03 14.62 13.46 4.79
Debt to NOPAT
7.09 -205.68 13.22 1.20 11.35 -47.20 37.10 11.88 158.35 243.28 9.02
Net Debt to NOPAT
5.25 -156.60 9.57 0.86 7.04 -29.89 25.18 8.21 112.44 181.67 7.68
Long-Term Debt to NOPAT
5.98 -168.12 12.29 1.13 11.26 -43.22 36.71 11.70 154.00 236.53 8.94
Altman Z-Score
2.43 2.04 1.94 3.96 2.27 2.19 2.43 2.30 1.65 1.78 2.16
Noncontrolling Interest Sharing Ratio
69.84% 79.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.02 1.00 1.37 1.43 1.42 1.13 1.10 1.04 1.08 0.79 0.71
Quick Ratio
0.95 0.92 1.12 1.03 1.30 1.01 0.95 0.92 0.73 0.71 0.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
228 184 49 3,409 276 229 68 290 718 33 183
Operating Cash Flow to CapEx
456.22% 350.47% 384.08% 250.09% 195.17% 287.63% 163.83% 211.84% 102.54% 316.52% 578.26%
Free Cash Flow to Firm to Interest Expense
2.60 2.06 0.42 29.54 2.49 2.17 0.70 5.61 11.35 0.51 1.80
Operating Cash Flow to Interest Expense
5.97 5.58 3.85 2.99 2.42 2.86 3.11 3.38 1.27 3.60 3.78
Operating Cash Flow Less CapEx to Interest Expense
4.66 3.99 2.85 1.79 1.18 1.86 1.21 1.78 0.03 2.46 3.12
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.57 0.44 0.44 0.89 0.56 0.66 0.72 0.51 0.46 0.53 0.58
Accounts Receivable Turnover
7.83 5.70 6.31 14.11 8.60 9.32 10.15 7.32 7.65 11.25 11.54
Inventory Turnover
17.95 13.60 19.89 34.75 29.46 34.42 34.01 16.38 13.42 14.66 12.81
Fixed Asset Turnover
11.63 8.24 8.09 14.60 8.27 9.26 8.59 5.44 8.81 15.19 8.35
Accounts Payable Turnover
1.03 0.87 0.94 1.28 1.80 2.87 2.83 1.45 1.13 1.06 0.94
Days Sales Outstanding (DSO)
46.61 64.05 57.85 25.86 42.44 39.16 35.96 49.85 47.74 32.44 31.63
Days Inventory Outstanding (DIO)
20.33 26.84 18.35 10.50 12.39 10.60 10.73 22.28 27.19 24.90 28.50
Days Payable Outstanding (DPO)
353.77 417.91 390.01 286.14 203.31 127.07 128.97 251.12 321.73 345.07 388.62
Cash Conversion Cycle (CCC)
-286.83 -327.02 -313.81 -249.78 -148.49 -77.30 -82.28 -178.99 -246.80 -287.74 -328.48
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,658 2,458 2,699 2,013 1,978 1,695 1,690 1,585 880 855 894
Invested Capital Turnover
1.40 1.04 1.08 2.39 1.61 1.94 2.17 1.52 1.69 2.34 2.16
Increase / (Decrease) in Invested Capital
188 -200 241 -686 -35 -283 -5.04 -105 -705 -25 38
Enterprise Value (EV)
5,103 4,463 4,267 3,201 2,258 2,534 2,598 2,125 2,268 2,742 3,397
Market Capitalization
2,623 1,901 1,494 862 558 910 1,021 601 744 1,308 1,701
Book Value per Share
$0.91 ($0.56) $1.01 $0.54 $1.67 $0.41 $0.64 $0.35 ($2.09) ($3.18) ($4.99)
Tangible Book Value per Share
($8.90) ($9.91) ($9.95) ($7.69) ($7.19) ($7.17) ($6.56) ($6.23) ($6.37) ($7.24) ($9.72)
Total Capital
3,426 3,261 4,019 3,367 3,026 2,635 2,436 2,266 1,777 1,341 1,191
Total Debt
2,951 3,365 3,830 3,266 2,740 2,564 2,324 2,205 2,146 1,920 1,993
Total Long-Term Debt
2,490 2,750 3,559 3,066 2,720 2,348 2,299 2,173 2,087 1,866 1,976
Net Debt
2,183 2,562 2,772 2,339 1,699 1,624 1,577 1,524 1,524 1,434 1,696
Capital Expenditures (CapEx)
115 142 118 138 137 105 184 83 78 72 66
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-260 -191 -26 81 -354 -482 -558 -578 -404 -788 -727
Debt-free Net Working Capital (DFNWC)
507 612 1,032 1,007 686 458 189 103 219 -302 -430
Net Working Capital (NWC)
46 -2.44 761 808 666 242 164 70 160 -355 -447
Net Nonoperating Expense (NNE)
-10 -128 46 2,481 47 126 64 149 399 211 76
Net Nonoperating Obligations (NNO)
2,183 2,562 2,510 1,911 1,692 1,624 1,577 1,524 1,248 1,434 1,696
Total Depreciation and Amortization (D&A)
173 174 127 155 170 171 170 120 123 127 119
Debt-free, Cash-free Net Working Capital to Revenue
-7.27% -7.19% -0.93% 1.43% -11.04% -13.57% -15.19% -23.29% -19.42% -38.86% -38.43%
Debt-free Net Working Capital to Revenue
14.18% 23.05% 37.07% 17.87% 21.42% 12.89% 5.14% 4.15% 10.51% -14.88% -22.73%
Net Working Capital to Revenue
1.29% -0.09% 27.34% 14.33% 20.79% 6.81% 4.47% 2.83% 7.68% -17.51% -23.64%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.04 $0.49 $1.40 $1.19 $1.10 ($1.06) ($0.01) $0.21 ($2.20) ($1.13) $0.84
Adjusted Weighted Average Basic Shares Outstanding
191.56M 186.40M 186.78M 188.24M 171.15M 173.27M 174.86M 174.18M 176.53M 182.79M 149.94M
Adjusted Diluted Earnings per Share
$2.03 $0.49 $1.39 $1.19 $1.10 ($1.06) ($0.01) $0.21 ($2.20) ($1.12) $0.84
Adjusted Weighted Average Diluted Shares Outstanding
191.56M 186.40M 186.78M 188.24M 171.15M 173.27M 174.86M 174.18M 176.53M 182.79M 149.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $1.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
191.56M 186.40M 186.78M 188.24M 171.15M 173.27M 174.86M 174.18M 176.53M 182.79M 149.94M
Normalized Net Operating Profit after Tax (NOPAT)
434 122 335 2,756 162 105 105 186 135 124 285
Normalized NOPAT Margin
12.12% 4.58% 12.03% 48.90% 5.06% 2.94% 2.86% 7.48% 6.47% 6.11% 15.07%
Pre Tax Income Margin
17.07% 7.60% 6.96% 46.37% 0.83% -5.16% -0.20% 7.60% -2.11% -2.58% 10.17%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.97 3.27 2.64 23.66 1.24 -0.73 0.92 4.64 0.31 0.18 2.90
NOPAT to Interest Expense
4.75 -0.18 2.46 23.60 2.18 -0.51 0.65 3.59 0.21 0.12 2.18
EBIT Less CapEx to Interest Expense
6.67 1.68 1.64 22.46 0.00 -1.73 -0.98 3.05 -0.93 -0.96 2.24
NOPAT Less CapEx to Interest Expense
3.44 -1.78 1.45 22.40 0.94 -1.51 -1.25 1.99 -1.02 -1.01 1.52
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
39.52% 142.28% 57.28% 58.10% 18.20% -19.01% -2,575.87% 93.98% -9.13% -17.66% 35.29%
Augmented Payout Ratio
70.42% 586.86% 57.28% 58.10% 72.23% -19.01% -2,575.87% 130.38% -9.13% -17.66% 296.77%

Quarterly Metrics And Ratios for Pitney Bowes

This table displays calculated financial ratios and metrics derived from Pitney Bowes' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 299,885,396.00 135,441,425.00 137,090,212.00
DEI Adjusted Shares Outstanding
- - - - - - - - 299,885,396.00 135,441,425.00 137,090,212.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.19 0.37 0.38
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.48% 2.15% -0.71% -174.84% -5.34% -5.68% -7.97% -7.46% -3.24% -2.25% -0.76%
EBITDA Growth
44.30% 122.48% -139.11% -66.10% -5.01% 81.64% 683.49% 781.84% 23.43% 26.86% -4.26%
EBIT Growth
108.73% 83.33% -163.52% -91.02% -5.22% 214.76% 684.61% 401.31% 34.74% 46.51% -1.01%
NOPAT Growth
-188.93% 83.33% -167.22% -95.65% 6.53% 243.22% 736.85% 406.61% 28.43% 46.27% -2.46%
Net Income Growth
62.71% 82.43% -1,006.09% 83.30% 1,327.80% 220.54% 137.53% 173.15% 64.13% 66.50% 1.35%
EPS Growth
50.00% 82.72% -971.43% 83.59% 1,050.00% 221.43% 140.00% 185.71% 105.26% 111.76% 23.33%
Operating Cash Flow Growth
68.46% 211,131.82% -44.44% 43.06% -32.28% 20.35% 353.33% 64.86% 364.73% 37.28% 126.10%
Free Cash Flow Firm Growth
12,454.81% 355.31% 137.02% -96.42% -60.09% -83.76% -104.76% -21.85% -17.45% 230.40% 4,658.91%
Invested Capital Growth
-29.42% -28.49% -30.22% -2.81% -13.83% -2.15% 9.09% 4.49% -10.29% -15.79% -30.46%
Revenue Q/Q Growth
-4.71% -4.50% -37.03% -119.33% 611.08% -6.39% -0.48% 3.90% -0.04% -5.43% 1.04%
EBITDA Q/Q Growth
160.36% -78.43% -195.61% 296.71% 155.31% -6.96% 30.65% -24.17% 57.01% -18.44% 10.35%
EBIT Q/Q Growth
126.26% -142.00% -22.41% 127.76% 820.43% -9.57% 46.74% -31.48% 84.73% -21.12% 14.62%
NOPAT Q/Q Growth
88.81% 1.41% -22.41% 114.80% 1,769.10% -8.94% 46.59% -35.99% 87.36% -16.80% 13.01%
Net Income Q/Q Growth
98.71% -761.94% -456.85% 73.01% 194.78% -15.38% 73.35% -47.39% 112.67% -14.16% 5.53%
EPS Q/Q Growth
98.44% -600.00% -435.71% 72.00% 190.48% -10.53% 76.47% -40.00% 116.67% -7.69% 2.78%
Operating Cash Flow Q/Q Growth
-113.34% 841.35% -84.53% 836.35% -112.40% 767.83% -39.99% 231.65% -80.08% 246.32% -1.16%
Free Cash Flow Firm Q/Q Growth
69.52% -14.48% 1.08% -93.42% 698.29% -67.18% -128.19% 137.29% 2,436.86% 23.90% 74.98%
Invested Capital Q/Q Growth
4.30% -10.09% -6.29% -15.69% 21.30% 2.10% 4.48% -19.25% 4.15% -4.16% -13.72%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.15% 33.62% 55.57% 0.00% 54.54% 53.59% 53.14% 67.93% 57.09% 56.41% 56.79%
EBITDA Margin
11.80% 2.66% -4.05% 0.00% 20.57% 20.44% 26.83% 19.58% 30.76% 26.53% 28.98%
Operating Margin
6.51% -2.86% -5.56% 0.00% 14.39% 13.90% 20.50% 13.52% 24.98% 20.84% 23.64%
EBIT Margin
6.51% -2.86% -5.56% 0.00% 14.39% 13.90% 20.50% 13.52% 24.98% 20.84% 23.64%
Profit (Net Income) Margin
-0.35% -3.14% -27.72% 0.00% 7.18% 6.49% 11.30% 5.72% 12.18% 11.05% 11.55%
Tax Burden Percent
-29.82% 64.32% 315.57% -181.93% 75.80% 76.33% 76.25% 71.23% 72.24% 76.21% 75.14%
Interest Burden Percent
17.90% 170.33% 157.93% 266.31% 65.82% 61.16% 72.33% 59.45% 67.48% 69.62% 65.01%
Effective Tax Rate
129.82% 0.00% 0.00% 62.67% 24.20% 23.67% 23.75% 28.77% 27.76% 23.79% 24.86%
Return on Invested Capital (ROIC)
-4.35% -5.06% -10.34% 0.00% 19.45% 19.53% 28.46% 20.84% 34.42% 30.38% 35.27%
ROIC Less NNEP Spread (ROIC-NNEP)
-3.54% -5.64% -17.99% 0.00% 18.29% 18.30% 27.26% 19.65% 32.77% 29.08% 33.59%
Return on Net Nonoperating Assets (RNNOA)
34.48% 34.73% 86.91% 0.00% -62.46% -58.94% -76.23% -44.53% -77.88% -69.59% -75.64%
Return on Equity (ROE)
30.13% 29.67% 76.58% 0.00% -43.01% -39.41% -47.77% -23.69% -43.46% -39.22% -40.37%
Cash Return on Invested Capital (CROIC)
21.12% 24.35% 22.21% 3.76% 15.32% 5.52% 2.13% 20.88% 35.26% 44.12% 63.79%
Operating Return on Assets (OROA)
4.92% -2.21% -4.52% 0.00% 7.80% 7.49% 11.47% 7.79% 14.61% 12.43% 14.09%
Return on Assets (ROA)
-0.26% -2.42% -22.50% 0.00% 3.89% 3.50% 6.32% 3.30% 7.12% 6.59% 6.88%
Return on Common Equity (ROCE)
30.13% 29.67% 76.58% 0.00% -43.01% -39.41% -47.77% -23.69% -43.46% -39.22% -40.37%
Return on Equity Simple (ROE_SIMPLE)
97.05% 61.72% 75.17% 0.00% 30.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -16 -19 2.88 54 49 72 46 86 72 81
NOPAT Margin
-1.94% -2.00% -3.89% 0.00% 10.91% 10.61% 15.63% 9.63% 18.05% 15.88% 17.76%
Net Nonoperating Expense Percent (NNEP)
-0.82% 0.58% 7.65% 3.00% 1.16% 1.23% 1.20% 1.19% 1.65% 1.30% 1.68%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.21% 3.91% 3.60% 4.98% 3.86% 6.92% 6.12% 7.71%
Cost of Revenue to Revenue
65.85% 66.38% 44.43% 0.00% 45.46% 46.41% 46.86% 32.07% 42.91% 43.59% 43.21%
SG&A Expenses to Revenue
26.03% 27.74% 38.04% 0.00% 33.63% 36.92% 31.36% 29.51% 27.94% 28.52% 30.51%
R&D to Revenue
1.14% 1.15% 1.52% 0.00% 0.97% 0.78% 0.74% 0.73% 0.79% 0.75% 0.74%
Operating Expenses to Revenue
27.65% 36.48% 61.14% 0.00% 40.15% 39.69% 32.65% 54.41% 32.11% 35.58% 33.15%
Earnings before Interest and Taxes (EBIT)
54 -23 -28 7.71 71 64 94 65 119 94 108
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
98 21 -20 40 101 94 123 94 147 120 132
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.23 0.28 0.39 0.65 0.83 1.00 1.02 0.90 0.88 1.27 1.20
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 24.55 11.75 9.90 12.67 11.90
Dividend Yield
5.87% 3.96% 2.81% 2.78% 2.32% 2.11% 2.72% 3.31% 2.99% 2.05% 2.33%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.07% 8.51% 10.10% 7.90% 8.41%
Enterprise Value to Invested Capital (EV/IC)
1.95 2.23 2.77 3.21 3.11 3.37 3.37 3.80 3.74 4.63 4.99
Enterprise Value to Revenue (EV/Rev)
0.72 0.74 0.86 1.35 1.61 1.81 1.93 1.79 1.86 2.21 2.06
Enterprise Value to EBITDA (EV/EBITDA)
0.00 234.07 0.00 19.77 24.21 20.33 13.17 8.23 7.90 8.86 8.35
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 243.21 438.21 69.83 23.11 11.55 10.72 11.64 10.87
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 347.45 626.01 99.76 32.52 15.37 14.49 15.69 14.71
Enterprise Value to Operating Cash Flow (EV/OCF)
22.01 12.09 14.96 11.96 14.34 14.65 12.61 8.86 7.84 8.50 6.74
Enterprise Value to Free Cash Flow (EV/FCFF)
7.64 7.63 10.26 84.06 18.80 60.43 165.51 18.61 10.03 9.59 6.42
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-5.44 -4.96 -4.06 -3.32 -3.57 -3.53 -3.18 -2.48 -2.39 -2.36 -2.26
Long-Term Debt to Equity
-5.29 -4.83 -3.96 -3.23 -3.54 -3.51 -3.16 -2.46 -1.99 -2.33 -2.23
Financial Leverage
-9.75 -6.16 -4.83 -2.83 -3.41 -3.22 -2.80 -2.27 -2.38 -2.39 -2.25
Leverage Ratio
-25.98 -16.89 -12.53 -8.10 -7.94 -7.59 -5.85 -4.76 -4.49 -4.47 -4.17
Compound Leverage Factor
-4.65 -28.77 -19.79 -21.57 -5.23 -4.64 -4.23 -2.83 -3.03 -3.11 -2.71
Debt to Total Capital
122.53% 125.25% 132.64% 143.13% 138.91% 139.47% 145.86% 167.39% 171.79% 173.75% 179.64%
Short-Term Debt to Total Capital
3.34% 3.38% 3.55% 3.97% 1.03% 1.11% 1.12% 1.44% 29.24% 1.98% 2.35%
Long-Term Debt to Total Capital
119.19% 121.87% 129.08% 139.16% 137.88% 138.36% 144.74% 165.95% 142.55% 171.77% 177.28%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-22.53% -25.25% -32.64% -43.13% -38.91% -39.47% -45.86% -67.39% -71.79% -73.75% -79.64%
Debt to EBITDA
-20.36 205.89 -34.26 13.84 14.35 10.79 7.43 4.83 4.85 4.36 4.10
Net Debt to EBITDA
-15.22 146.52 -24.91 10.34 11.80 9.08 6.24 4.11 4.14 3.77 3.49
Long-Term Debt to EBITDA
-19.80 200.33 -33.34 13.46 14.24 10.71 7.37 4.79 4.03 4.31 4.05
Debt to NOPAT
-10.97 -18.44 -12.77 243.28 371.09 52.95 18.33 9.02 8.90 7.73 7.22
Net Debt to NOPAT
-8.21 -13.12 -9.28 181.67 305.15 44.55 15.40 7.68 7.59 6.67 6.15
Long-Term Debt to NOPAT
-10.67 -17.94 -12.43 236.53 368.34 52.53 18.19 8.94 7.38 7.64 7.13
Altman Z-Score
1.96 1.90 2.05 1.78 1.97 2.01 2.03 1.93 1.90 2.19 2.19
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.97 0.96 0.88 0.79 0.80 0.76 0.81 0.71 0.62 0.73 0.70
Quick Ratio
0.86 0.85 0.77 0.71 0.69 0.65 0.70 0.62 0.52 0.63 0.60
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
486 415 420 28 220 72 -20 7.60 193 239 418
Operating Cash Flow to CapEx
-62.76% 439.32% 157.34% 606.25% -98.77% 834.80% 423.17% 1,094.76% 278.65% 827.25% 1,411.20%
Free Cash Flow to Firm to Interest Expense
10.94 26.01 26.08 0.00 9.08 2.90 -0.78 0.29 4.97 8.36 11.08
Operating Cash Flow to Interest Expense
-0.28 5.82 0.89 0.00 -0.69 4.47 2.56 8.47 1.14 5.35 4.01
Operating Cash Flow Less CapEx to Interest Expense
-0.73 4.49 0.33 0.00 -1.38 3.93 1.96 7.69 0.73 4.70 3.72
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.76 0.77 0.81 0.53 0.54 0.54 0.56 0.58 0.58 0.60 0.60
Accounts Receivable Turnover
11.27 12.16 13.72 11.25 8.55 9.35 11.02 11.54 11.77 12.31 11.50
Inventory Turnover
25.87 26.50 28.74 14.66 12.49 11.23 11.54 12.81 12.61 11.32 11.53
Fixed Asset Turnover
7.85 14.57 14.89 15.19 6.43 16.52 16.77 8.35 8.68 9.01 9.30
Accounts Payable Turnover
2.82 2.71 2.71 1.06 1.18 1.10 1.10 0.94 1.07 1.08 1.07
Days Sales Outstanding (DSO)
32.37 30.01 26.60 32.44 42.68 39.03 33.12 31.63 31.01 29.65 31.73
Days Inventory Outstanding (DIO)
14.11 13.77 12.70 24.90 29.23 32.51 31.62 28.50 28.94 32.23 31.65
Days Payable Outstanding (DPO)
129.40 134.72 134.51 345.07 310.59 331.59 332.95 388.62 342.39 337.58 341.10
Cash Conversion Cycle (CCC)
-82.92 -90.94 -95.21 -287.74 -238.68 -260.05 -268.20 -328.48 -282.44 -275.70 -277.72
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,204 1,082 1,014 855 1,037 1,059 1,107 894 931 892 770
Invested Capital Turnover
2.24 2.53 2.65 2.34 1.78 1.84 1.82 2.16 1.91 1.91 1.99
Increase / (Decrease) in Invested Capital
-502 -431 -439 -25 -167 -23 92 38 -107 -167 -337
Enterprise Value (EV)
2,347 2,413 2,813 2,742 3,227 3,573 3,732 3,397 3,481 4,128 3,844
Market Capitalization
751 902 1,280 1,308 1,654 1,977 1,964 1,701 1,657 2,373 2,237
Book Value per Share
($2.19) ($2.39) ($2.89) ($3.18) ($2.93) ($2.96) ($3.84) ($4.99) ($5.96) ($6.37) ($6.10)
Tangible Book Value per Share
($6.60) ($6.76) ($7.09) ($7.24) ($7.02) ($7.18) ($8.27) ($9.72) ($11.01) ($11.94) ($11.58)
Total Capital
1,742 1,694 1,590 1,341 1,377 1,360 1,443 1,191 1,245 1,171 1,051
Total Debt
2,134 2,122 2,109 1,920 1,913 1,897 2,104 1,993 2,138 2,034 1,887
Total Long-Term Debt
2,076 2,065 2,052 1,866 1,899 1,882 2,088 1,976 1,774 2,011 1,863
Net Debt
1,596 1,510 1,533 1,434 1,573 1,596 1,768 1,696 1,824 1,755 1,606
Capital Expenditures (CapEx)
20 21 9.13 22 17 13 16 20 16 18 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-523 -627 -717 -788 -630 -649 -592 -727 -639 -633 -709
Debt-free Net Working Capital (DFNWC)
15 -15 -142 -302 -290 -348 -256 -430 -325 -355 -428
Net Working Capital (NWC)
-43 -72 -198 -355 -304 -363 -272 -447 -689 -378 -452
Net Nonoperating Expense (NNE)
-13 8.98 119 40 18 19 20 19 28 22 28
Net Nonoperating Obligations (NNO)
1,596 1,510 1,533 1,434 1,573 1,596 1,768 1,696 1,824 1,755 1,606
Total Depreciation and Amortization (D&A)
44 44 7.58 32 30 30 29 29 28 26 24
Debt-free, Cash-free Net Working Capital to Revenue
-16.04% -19.13% -21.90% -38.86% -31.52% -32.91% -30.66% -38.43% -34.06% -33.94% -38.06%
Debt-free Net Working Capital to Revenue
0.45% -0.46% -4.33% -14.88% -14.51% -17.64% -13.26% -22.73% -17.33% -19.00% -22.96%
Net Working Capital to Revenue
-1.33% -2.21% -6.06% -17.51% -15.22% -18.41% -14.09% -23.64% -36.72% -20.24% -24.29%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.02) ($0.14) ($0.77) ($0.20) $0.19 $0.17 $0.31 $0.17 $0.40 $0.37 $0.39
Adjusted Weighted Average Basic Shares Outstanding
178.88M 179.51M 181.70M 182.79M 181.25M 172.12M 160.92M 149.94M 135.44M 137.09M 135.55M
Adjusted Diluted Earnings per Share
($0.02) ($0.14) ($0.75) ($0.21) $0.19 $0.17 $0.30 $0.18 $0.39 $0.36 $0.37
Adjusted Weighted Average Diluted Shares Outstanding
178.88M 179.51M 181.70M 182.79M 181.25M 172.12M 160.92M 149.94M 135.44M 137.09M 135.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
178.88M 179.51M 181.70M 182.79M 181.25M 172.12M 160.92M 149.94M 135.44M 137.09M 135.55M
Normalized Net Operating Profit after Tax (NOPAT)
41 6.40 37 39 73 55 72 83 90 75 80
Normalized NOPAT Margin
4.92% 0.81% 7.46% 0.00% 14.84% 11.80% 15.77% 17.36% 18.82% 16.52% 17.49%
Pre Tax Income Margin
1.16% -4.87% -8.79% 0.00% 9.47% 8.50% 14.82% 8.04% 16.86% 14.51% 15.36%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.22 -1.42 -1.73 0.00 2.93 2.57 3.61 2.47 3.07 3.29 2.86
NOPAT to Interest Expense
-0.36 -1.00 -1.21 0.00 2.22 1.97 2.76 1.76 2.22 2.51 2.15
EBIT Less CapEx to Interest Expense
0.77 -2.75 -2.29 0.00 2.23 2.04 3.01 1.69 2.67 2.64 2.57
NOPAT Less CapEx to Interest Expense
-0.81 -2.32 -1.78 0.00 1.52 1.43 2.15 0.98 1.81 1.86 1.86
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-9.28% -13.43% -9.16% -17.66% -23.05% -37.83% 57.53% 35.29% 31.90% 29.01% 29.12%
Augmented Payout Ratio
-9.28% -13.43% -9.16% -17.66% -32.13% -119.56% 372.30% 296.77% 329.97% 283.37% 205.83%

Financials Breakdown Chart

Key Financial Trends

Pitney Bowes’ recent financial statements show a business that has returned to profitability, although revenue remains below historical levels and the balance sheet is highly leveraged. In Q2 2026, revenue declined 2.3% year over year to $451.5 million, but net income increased 66% to $49.9 million. Gross margin was approximately 56.4%, while operating margin improved to 20.8% from 13.9% in Q2 2025, helped by lower selling, general and administrative expenses, other operating expenses and restructuring charges.

Cash generation has also strengthened. Operating cash flow rose to $152.9 million in Q2 2026 from $111.4 million a year earlier, and was substantially higher than the $44.2 million reported in Q1 2026. However, heavy financing outflows—including $362.3 million of debt repayments, $52.8 million of share repurchases and $13.6 million of dividends—resulted in a $36.0 million decline in cash during the quarter. The company issued $249.0 million of debt, indicating that refinancing remains an important part of its liquidity management.

Over the broader period provided, Pitney Bowes has made progress from the large losses reported in 2023 and 2024, but its capital structure remains a significant risk. Revenue has generally trended lower from more than $800 million in early 2023 to roughly $450 million in recent quarters, while total shareholders’ equity has remained negative. Investors should also note that several historical figures were restated and that discontinued operations and divestitures make direct multi-year comparisons more difficult.

  • Profitability has improved: Q2 2026 net income reached $49.9 million, compared with $30.0 million in restated Q2 2025 and losses in several 2023 and 2024 periods.
  • Operating margins expanded: Q2 2026 operating income increased to $94.1 million, producing an operating margin of about 20.8%, versus approximately 13.9% a year earlier.
  • Operating cash flow strengthened: Cash generated from operations increased 37% year over year to $152.9 million, providing meaningful support for debt service and ongoing operations.
  • Cost control is contributing to the recovery: Q2 selling, general and administrative expense fell to $128.7 million from $170.5 million in Q2 2025, while restructuring charges also declined.
  • Share count has declined over time: Weighted average basic shares fell to 137.1 million in Q2 2026 from 172.1 million in Q2 2025 and more than 181 million in early 2025, supporting per-share results when earnings are positive.
  • Revenue remains under pressure: Q2 2026 revenue declined from $461.9 million a year earlier and is well below the levels reported in 2023 and early 2024, although divestitures and discontinued operations affect comparisons.
  • Cash balances are declining: Cash and equivalents fell to $266.8 million at June 30, 2026, from $285.2 million at June 30, 2025 and more than $590 million in Q2 2024.
  • Leverage remains elevated: Short- and long-term debt totaled approximately $2.04 billion in Q2 2026, exceeding the company’s $266.8 million cash balance by a wide margin.
  • Shareholders’ equity is deeply negative: Total equity was negative $863.3 million at the end of Q2 2026, worsening from negative $536.8 million in Q2 2025. This leaves limited balance-sheet protection for common shareholders.
  • Capital allocation is aggressive relative to the balance sheet: Pitney Bowes repurchased nearly $316 million of stock across Q4 2025, Q1 2026 and Q2 2026 while also relying on debt issuance and maintaining a negative equity position.
11/16/26 09:16 PM ETAI Generated. May Contain Errors.

Pitney Bowes Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Pitney Bowes' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Pitney Bowes' net income appears to be on a downward trend, with a most recent value of $144.70 million in 2025, falling from $426.32 million in 2015. The previous period was -$203.60 million in 2024. See where experts think Pitney Bowes is headed by visiting Pitney Bowes' forecast page.

Pitney Bowes' total operating income in 2025 was $293.98 million, based on the following breakdown:
  • Total Gross Profit: $1.09 billion
  • Total Operating Expenses: $791.38 million

Over the last 10 years, Pitney Bowes' total revenue changed from $3.58 billion in 2015 to $1.89 billion in 2025, a change of -47.1%.

In the past 13 quarters, Pitney Bowes' cash and equivalents has ranged from $266.83 million in Q2 2026 to $590.15 million in Q2 2024, and is currently $268.51 million as of their latest financial filing in Q3 2026.

Pitney Bowes had total debt of $1.99 billion at the end of 2025, a 3.8% increase from 2024, and a 32.5% decrease since 2015.

Over the last 10 years, Pitney Bowes' book value per share changed from 0.91 in 2015 to -4.99 in 2025.



Financial statements for NYSE:PBI last updated on 10/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners